
AP PHOTO
The feds are moving weed closer to Schedule III and cracking down on possession simultaneously. Here's what's actually going on.
Federal marijuana rescheduling is the most talked-about cannabis policy story right now, and also the most misunderstood.
Here’s what’s confusing people: the federal government is in the middle of loosening how it classifies marijuana, while at the same time prosecuting people for simple possession. This feels like a strong contradiction to many, but the rescheduling makes a lot more sense once understanding what it does and doesn’t change.
This article breaks down where federal marijuana rescheduling actually stands, what changed under the current DOJ, and what all of it means if you’re someone who uses cannabis in 2026.

Most people have a vague sense that rescheduling is “in the works.” Here’s a timeline of events related to the federal marijuana rescheduling, including where things stand today:
October, 2022: The push toward federal marijuana rescheduling started back in October 2022, when President Biden directed the Department of Health and Human Services (HHS) and the DEA to formally review marijuana’s Schedule I classification.
August 2023: In August, the HHS completed that review and recommended moving marijuana to Schedule III, based on updated medical and abuse evaluations.
May 2024: The DOJ published a proposed rule to transfer marijuana from Schedule I to Schedule III marijuana status, officially kicking off the formal rulemaking process under the Controlled Substances Act. That process requires public hearings and a full administrative record. The DEA scheduled hearings to begin in December 2024, but a judge postponed those proceedings in January 2025.
December 2025: President Trump signed an executive order directing the Attorney General to complete the Schedule III marijuana reclassification.
January 2026: the DEA publicly clarified that even with an executive order, the rescheduling still has to go through the required administrative steps before any schedule change becomes law.
As of early 2026, the rule is still proposed, not final. The hearings are still in limbo. Cannabis rescheduling news keeps generating headlines, but no final rescheduling action has occurred. Marijuana is still Schedule I under federal law right now.
Schedule III is not legalization. The DEA’s own rescheduling notice says that even under Schedule III, marijuana would still be subject to the criminal prohibitions of the Controlled Substances Act. That’s straight from the federal government.
Here’s what federal marijuana rescheduling would change:
Here’s what it wouldn’t change:
Even with Schedule III rescheduling, your use of cannabis would still be considered a federal crime. Legal scholars at Ohio State’s Drug Enforcement and Policy Center have been clear: rescheduling is an administrative classification change, not a reform of prohibition. The DEA keeps full enforcement no matter what schedule marijuana lands in.
That distinction between marijuana rescheduling 2026 expectations and the legal reality is something most readers don’t fully grasp, and it’s the key to understanding the contradiction we’re about to get into.

Biden issued mass pardons for federal simple-possession marijuana offenses, covering offenses on December 22, 2023. He publicly called on governors to issue similar relief at the state level. Behind the scenes, an internal DOJ memo instructed U.S. Attorneys to dismiss simple-possession cases, withdraw warrants and fees, and be careful before bringing any new cannabis cases.
In other words, Marijuana remained Schedule I, but the federal government was stepping back from low-level possession cases. For a lot of cannabis consumers, this felt like a big shift. It wasn’t. It was “prosecutorial discretion,” and prosecutorial discretion can be reversed by the next administration.
Which is exactly what happened.
On September 29, 2025, the DOJ quietly rescinded Biden’s cannabis enforcement guidance. The public only found out about it because the U.S. Attorney’s Office for the District of Wyoming announced it.
Wyoming U.S. Attorney Darin Smith issued a memo stating that marijuana cases on federal land would now be “rigorously prosecuted,” reversing the prior standard.
Smith’s statement didn’t mince words: “Marijuana possession remains a federal crime in the United States, irrespective of varying state laws.” A spokesperson for his office told WyoFile that the Trump administration considers cannabis use a “public safety hazard.”
Congresswoman Dina Titus, co-chair of the Congressional Cannabis Caucus, sent AG Pam Bondi a letter demanding an explanation, pointing out the direct conflict between Biden’s pardons and the new prosecution directive. The Pam Bondi marijuana prosecutions story became a major flashpoint in cannabis rescheduling news.
According to the letter, the DOJ cannot undo Biden’s signed pardons since they are protected by the U.S. Constitution. What they can do is refuse to support expungement (the clearing or hiding of criminal records) or other relief for pardoned individuals, aggressively go after any new post-pardon possession, and reinstate maximum charging policies going forward.
The bottom line for cannabis consumers under Trump marijuana policy 2026: if you’re on federal land like national parks, federal buildings, or military bases, you’re back in real legal jeopardy for simple possession. The soft-enforcement window from the Biden era is closed.
Interestingly, former U.S. Attorneys from five different districts told Cannabis Business Times they never received any formal Biden-era memo telling them not to prosecute marijuana cases, which makes the whole situation even murkier.

hERB
This is the part that confuses people, and it’s the most important thing to understand about federal marijuana rescheduling right now.
Rescheduling and prosecution policy operate on entirely separate legal tracks. One is an administrative rulemaking process run by the DEA, the other is prosecutorial discretion by U.S. Attorneys under the direction of the Attorney General. They’re different mechanisms under the law, and they don’t need to agree with each other.
The DOJ marijuana enforcement policy shift under Bondi doesn’t legally conflict with the rescheduling process. Rescheduling to Schedule III marijuana changes how marijuana is classified. It doesn’t change whether it’s illegal to possess. Those are separate questions under the Controlled Substances Act, and the administration can advance one while going in the opposite direction on the other.
For marijuana rescheduling 2026, this creates a specific political dynamic. The White House can point to rescheduling progress as evidence of a modern approach to cannabis policy, while keeping full criminal leverage in federal prosecutions. The delayed hearings and indefinite rulemaking timeline make this approach easier to maintain because there’s no final rule forcing anyone to take a definitive position.
Trump marijuana policy 2026 is, in practice, a split screen: progress on paper, crackdowns on the ground.
The enforcement crackdown specifically targets federal land and federal jurisdiction. That means national parks, federal buildings, federally subsidized housing, and military installations. If you’re in a legal state and you’re not on federal property, day-to-day enforcement hasn’t changed much for most people.
But the risk is bigger for specific groups. If you live in federally subsidized housing, work on federal property, or use cannabis somewhere like Yellowstone, where you might not be thinking about federal jurisdiction, you’re exposed. Cannabis remains fully illegal under federal law, regardless of what your state says.
NORML called the new DOJ marijuana enforcement policy “inappropriate and misguided,” pointing out that nearly half of all U.S. states have legalized cannabis possession and that most Americans oppose using federal resources this way.
For cannabis businesses, the biggest outcome of federal marijuana rescheduling would be relief from 280E, the tax provision that stops cannabis companies from deducting normal business expenses because they sell a Schedule I substance. Schedule III marijuana would change that calculation overnight, and it’s the main reason industry advocates are watching the rescheduling hearings so closely, even though rescheduling won’t legalize anything.
But the mixed signals, enforcement tightening on one hand while cannabis rescheduling news about Schedule III progress trickles out on the other, are creating real uncertainty. Businesses that were planning around a more permissive federal environment are now hedging. And equity-focused small operators are particularly squeezed: the capital and compliance costs of navigating this environment favor large, well-funded companies over smaller ones trying to get a foothold.
Nine Republican members of Congress even wrote to AG Bondi in August 2025 opposing rescheduling, and the House Appropriations Committee advanced a funding bill that would block DOJ from using any funds to reschedule cannabis. So the opposition isn’t just theoretical. It’s legislative.

No. Moving marijuana to Schedule III changes its classification, not its legality. Possessing, buying, or selling marijuana without DEA authorization would still be a federal crime. Legalization would require an act of Congress, not a scheduling change.
No. Presidential pardons are constitutionally protected and can’t be reversed by a subsequent administration. However, the DOJ can refuse to support expungement efforts and can aggressively prosecute any new marijuana offenses going forward.
Federal land is the primary risk zone: national parks, federal buildings, military bases, and federally subsidized housing. If you’re in a legal state on non-federal property, day-to-day enforcement hasn’t changed significantly for most people.
Section 280E of the Internal Revenue Code prevents businesses that sell Schedule I or II substances from deducting normal business expenses on federal taxes. If marijuana moves to Schedule III, cannabis companies could finally take those deductions, which would be a huge financial shift for the industry.
There’s no clear timeline. Despite Trump’s December 2025 executive order directing the process to be expedited, the DEA confirmed in January 2026 that the full administrative rulemaking process still needs to be completed. Some analysts are modeling for a possible 2026 effective date, but litigation or procedural delays could push it further out.
It’s complicated. Trump signed the executive order to expedite marijuana rescheduling 2026 and said during the campaign that nobody should be arrested for personal amounts. But his DOJ under AG Bondi has simultaneously ramped up federal prosecution guidance for simple possession on federal land. The actions point in opposite directions, which is kind of the whole story here.

HERB
Federal marijuana rescheduling is real and still technically moving forward, but it doesn’t mean what most people think it means. Schedule III marijuana would be a meaningful shift for researchers and businesses, especially on the tax front. But for everyday cannabis users, it changes very little about your legal exposure, especially on federal land.
The DOJ marijuana enforcement policy under Bondi tells a different story than the rescheduling headlines. The contradiction isn’t an accident or an oversight. Two separate legal mechanisms are moving in two different directions at the same time, and understanding that is the only way to make sense of marijuana rescheduling 2026 and Trump marijuana policy 2026 as they stand today.
We’ll keep tracking the rescheduling hearings and enforcement developments as this unfolds.

ELSA OLOFSSON
For more than a decade, Herb has been a gathering place for people who love, use, and are simply curious about cannabis. What started as a small corner of the internet has grown into a community where millions come to learn, share, and stay connected to the culture.
Here’s what you can tap into at Herb:
Stay connected with the Herb community by subscribing to our newsletter, following us on Instagram, and X for the latest in cannabis lifestyle and culture.
Herb Recommended Products:
READ MORE